Habib Bank Limited Pharmaceutical Import Profile — Pakistan (DGFT 2022–2026)

Name: Habib Bank Limited Pharmaceutical Import Records from India — 3 Products, $1.3M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Habib Bank Limited — Pharmaceutical Importer Profile (2026) | 3 Products, $1.3M Trade | TransData Nexus

Who Are the Verified Indian Suppliers to Habib Bank Limited?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Cipla Limited	$894.2K	49	35.1%
Bharat Serums And Vaccines Limited	$875.7K	28	34.4%
Naprod Life Sciences Private Limited	$166.2K	7	6.5%
Jodas Expoim Private Limited	$146.4K	10	5.7%
Cohance Lifesciences Limited	$122.4K	5	4.8%
Celon Laboratories Private Limited	$99.4K	2	3.9%
Fresenius Kabi Oncology Limited	$94.9K	3	3.7%
Aarti Drugs Limited	$50.0K	2	2.0%
Venus Remedies Limited	$33.1K	6	1.3%
Zeon Health Industries	$27.6K	7	1.1%
Rumit Life Care	$17.0K	1	0.7%
Ra Chem Pharma Limited	$16.3K	1	0.6%
Riocare India Private Limited	$3.2K	1	0.1%

Habib Bank Limited sources from 13 verified Indian suppliers across 94 distinct formulations. The supply base is diversified across 13 suppliers, reducing single-source dependency risk.

What Formulations Does Habib Bank Limited Import?

Formulation	Value	Ships
Snake venom antiserum	$150.0K	3
Imatib alpha 100 capsules ( imatinib capsules 100 MG )(1x10's x 60120 packs =601200 nos	$150.0K	3
Snake venom antiserum (lyophilized)	$122.4K	3
Equirab 1000 IU/5ML [ rabies antiserum	$100.0K	2
Equirab 1000 IU/5ML [ rabies antiserum	$84.8K	2
Soranib 200 MG tablet (sorafenib)inv.qty.5120 Pack 1x30's=153600	$65.8K	3
Orlistat pellets	$64.0K

What Products Does Habib Bank Limited Import?

Top Products by Import Value

1Imatinib$750.0K 2Serum$500.0K 3Sorafenib$65.8K

Habib Bank Limited Therapeutic Categories — 2 Specializations

Habib Bank Limited imports across 2 therapeutic categories, with Advanced Oncology (62.0%), Other (38.0%), representing the largest segments. The portfolio is concentrated — top 5 products = 100% of total imports.

Advanced Oncology

2 products · 62.0% · $815.8K

Other

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Imatinib	Advanced Oncology	$750.0K	15	2.6%	6
2	Serum	Other	$500.0K	10	1.8%	12

Key Metrics

Total Import Value$1.3M

Products3

Shipments28

Categories2

CountryPakistan

#1 Rankings0

Indian Suppliers13

Formulations94

Top Categories

Advanced Oncology62.0%

Other38.0%

Indian Suppliers

Last updated: March 28, 2026

Habib Bank Limited — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Habib Bank Limited (HBL), established in 1941, is Pakistan's first commercial bank and a leading financial institution in the country. Headquartered in Karachi, HBL operates over 1,640 branches and 2,264 ATMs globally, serving more than 40 million clients. In 2004, the Aga Khan Fund for Economic Development (AKFED) acquired a 51% stake in HBL, gaining management control. By April 2015, the Government of Pakistan divested its remaining 41.5% shareholding, making HBL Pakistan's largest private bank.

While HBL is primarily a commercial bank, it has diversified its services to include trade financing and facilitating international transactions. This diversification has positioned HBL as a key player in Pakistan's pharmaceutical import sector, particularly in sourcing finished pharmaceutical formulations from India. The bank's extensive network and financial expertise enable it to manage complex import operations, ensuring the availability of essential medicines in Pakistan.

2Distribution Network

HBL's distribution network is extensive, with over 1,640 branches and 2,264 ATMs across Pakistan and international locations. This widespread presence facilitates efficient logistics and distribution of imported pharmaceutical products. The bank's robust financial infrastructure supports seamless transactions and supply chain management, ensuring timely delivery of medicines to various stakeholders within Pakistan's healthcare system.

Importing Pharmaceuticals into Pakistan — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Pakistan

1Regulatory Authority & Framework

The Drug Regulatory Authority of Pakistan (DRAP) is the primary regulatory body overseeing the import and distribution of pharmaceutical products in Pakistan. Established under the Drug Regulatory Authority of Pakistan Act, 2012, DRAP enforces the Drugs Act, 1976, and other relevant regulations to ensure the quality, safety, and efficacy of therapeutic goods. The Drugs (Labeling and Packaging) Rules, 1986, mandate that all imported packaged medicines display the name and prescription material in accordance with these regulations. (tipp.gov.pk)

2Import Licensing & GMP

To import pharmaceutical products into Pakistan, companies must obtain a Drug Import License (D.I.L.) from DRAP. The application process involves submitting necessary documents through DRAP's online portal, with a processing timeline of approximately five days. (dra.gov.pk) Additionally, imported pharmaceutical products must comply with Good Manufacturing Practice (GMP) standards recognized by DRAP, ensuring that products meet quality and safety requirements.

3Quality & Labeling

Imported pharmaceutical products must adhere to the Drugs (Labeling and Packaging) Rules, 1986, which require that all imported packaged medicines display the name and prescription material in accordance with these regulations. (tipp.gov.pk) This ensures that consumers and healthcare providers have access to accurate and essential information regarding the pharmaceutical products available in the market.

4Recent Regulatory Changes

In March 2026, DRAP published a draft of the Therapeutic Goods (Import and Export) Rules, 2026, proposing updates to the regulatory framework governing the import and export of therapeutic goods in Pakistan. (dra.gov.pk) These proposed changes aim to streamline procedures and enhance the efficiency of the import and export processes for pharmaceutical products.

TransData Nexus Research · Pakistan regulatory databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Buyer Matching: Habib Bank Limited identified across shipments using consignee name normalization.
2.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
3.Market Share: Calculated per product as Habib Bank Limited's capped value divided by total Indian exports for that product.
4.Shipment Count: Based on 28 individual customs records matching Habib Bank Limited.
5.Supplier Verification: Habib Bank Limited sources from 13 verified Indian suppliers across 94 formulations, confirmed from customs records.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

3 Products Tracked

2 therapeutic categories

Expert-Reviewed

By pharmaceutical trade specialists

Habib Bank Limited

Habib Bank Limited — Import Portfolio & Supplier Network

Who Are the Verified Indian Suppliers to Habib Bank Limited?

What Formulations Does Habib Bank Limited Import?

What Products Does Habib Bank Limited Import?

Top Products by Import Value

Habib Bank Limited Therapeutic Categories — 2 Specializations

Import Portfolio — Top 3 by Import Value

Key Metrics

Top Categories

Indian Suppliers

Habib Bank Limited — Corporate Profile & Information

1Company Overview

2Distribution Network

Related Trade Data

Need Detailed Data?

3Industry Role

Supplier Relationship Intelligence — Habib Bank Limited

1Sourcing Concentration Analysis

2Supply Chain Resilience

3Strategic Implications

Importing Pharmaceuticals into Pakistan — Regulatory Framework

1Regulatory Authority & Framework

2Import Licensing & GMP

3Quality & Labeling

4Recent Regulatory Changes

Habib Bank Limited — Procurement Pattern Analysis

1Product Strategy

2Sourcing Profile

3Market Positioning

Seller's Guide — How to Become a Supplier to Habib Bank Limited

1Opportunity Assessment

2Requirements & Qualifications

3How to Approach

Frequently Asked Questions — Habib Bank Limited

What products does Habib Bank Limited import from India?

Who supplies pharmaceuticals to Habib Bank Limited from India?

What is Habib Bank Limited's total pharmaceutical import value?

What therapeutic categories does Habib Bank Limited focus on?

Get Full Habib Bank Limited Import Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Data Source & Methodology